Diagnostic services provider Dr Lal Path Labs on Tuesday said its consolidated profit after tax declined 24.8% to Rs 72.4 crore in the second quarter ended September.
ADVERTISEMENT
The company had posted a profit after tax (PAT) of Rs 96.3 crore in the year-ago period, it said in a BSE filing.
ADVERTISEMENT
Its revenue from operations, however, grew 7.1% to Rs 533.8 crore during the period under review, from Rs 498.4 crore in the corresponding quarter of the previous year.
Dr Lal Path Labs said its non-COVID revenue increased 14.8% in Q2 FY23 to Rs 514 crore, from Rs 448 crore in the year-ago period.
RECOMMENDED FOR YOU
![](https://images.assettype.com/bloombergquint/2024-08-21/6lk3je6j/788508a2-98e5-4044-924e-b952cc485627.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
India On Sustainable Growth Path, Says RBI Governor Shaktikanta Das
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2020-11/4458175a-55ed-4b81-98a9-708f6218af24/TCI_Express_Ltd___image_Company_website_.png?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Operating Profit Margin To Improve To 14% In FY25: TCI Express CFO
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-08-07/1mtbl7km/istockphoto_1027139762_170667a.jpg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Dr Lal PathLabs Q1 Results: Profit Rises 29%, Beats Estimates
![timelogo](/images/amp-time.png)
![](https://images.assettype.com/bloombergquint/2024-07/f1421a31-cd75-48a6-94ae-511081f4e955/Signage_of_Vedanta_Ltd__outside_its_office_building___Source_Vijay_Sartape_BQ_Prime___2_.jpeg?rect=0%2C0%2C3500%2C1969&auto=format%2Ccompress&format=webp&w=75)
Vedanta Eyes $4 Billion Cash Flow In FY25, Remains On Deleveraging Path
![timelogo](/images/amp-time.png)